marginal hyperlipidemia
Conditions
Interventions
Group 1:Natto Hongqu Capsule
Group 2:Natto Hongqu and Ginkgo capsule
Group 3:Notoginseng Natto and Hongqu Capsule
Group 4:Placebo: Pregelatinized starch
Sponsors
School of Public Health, Southern Medical university
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Voluntary participants aged 30-65 who have lived in the area for more than five years. There were at least two blood lipid tests in half a year. The serum total cholesterol was 5.18-6.21 mmol/L, and the serum triglyceride was 1.70-2.25 mmol/L.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women, allergic constitution or allergic to this sample. 2. Complicated with serious diseases such as heart, liver, kidney and hematopoietic system, psychiatric patients. 3. Those who have taken lipid-lowering drugs in the past two weeks, which affects the judges of the results. 4. Hospitalized patients with hyperlipidemia. 5. Those who did not take the intervention according to the regulations during the preliminary experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood lipid level: total cholesterol, triglyceride, LDL-C and HDL-C; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Inflammatory Facctor: IL-6, TNF-a;markers of endothelial function: VCAM-1, ICAM-1, Endothelin-1, E-selectin; | — |
Countries
China
Contacts
Public ContactZhang Zheqing
Department of Nutrition and Food Hygiene, School of Public Health, Southern Medical University
Outcome results
None listed